Growth Metrics

ClearPoint Neuro (CLPT) Capital Expenditures (2018 - 2026)

ClearPoint Neuro's Capital Expenditures history spans 12 years, with the latest figure at $49000.0 for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 81.37% to $49000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $522000.0, a 89.82% increase, with the full-year FY2025 number at $522000.0, up 89.82% from a year prior.
  • Capital Expenditures hit $49000.0 in Q4 2025 for ClearPoint Neuro, down from $199000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for CLPT hit a ceiling of $323000.0 in Q2 2023 and a floor of -$35000.0 in Q2 2021.
  • Historically, Capital Expenditures has averaged $107500.0 across 5 years, with a median of $72500.0 in 2022.
  • Biggest five-year swings in Capital Expenditures: crashed 94.89% in 2024 and later soared 1558.33% in 2025.
  • Tracing CLPT's Capital Expenditures over 5 years: stood at $38000.0 in 2021, then rose by 2.63% to $39000.0 in 2022, then tumbled by 46.15% to $21000.0 in 2023, then soared by 1152.38% to $263000.0 in 2024, then crashed by 81.37% to $49000.0 in 2025.
  • Business Quant data shows Capital Expenditures for CLPT at $49000.0 in Q4 2025, $199000.0 in Q3 2025, and $91000.0 in Q2 2025.